PHARMACEUTICAL PRODUCTS : NOT MUCH PROGRESS IN COUNCIL DESPITE CYPRIOT EFFORTS.

Position::Brief article
 
FREE EXCERPT

In spite of the lack of enthusiasm of EU member states in connection with the proposal amending the directive on the transparency of prices of medicinal products, the Council is pressing on with its work. During a meeting of the member states' health ministers, on 7 December 2012, the Cyprus Presidency of the EU set out the state of play on the directive that it has led the way on so far.

It noted that all the countries have put out a general reservation on the proposal. The national parliaments of Austria and Luxembourg have adopted a reasoned opinion. Denmark, Malta, the UK and France have put out a parliamentary reservation. The latter has even sought to put together a blocking minority to reject the text but to no avail. After eight working group meetings, the Presidency proposed considerably rewriting the articles that pose most problems. These are Article 15 on consultation of the interested parties and Article 8 on the appeal procedures in case of failure to respect the deadlines.

It stipulates...

To continue reading

REQUEST YOUR TRIAL